OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.024B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.348B 26.52
Intuitive Surgical (ISRG) United States $203.988B 93.58
Alcon (ALC) Switzerland $45.073B 30.16
Edwards Lifesciences (EW) United States $41.952B 26.64
IQVIA Holdings (IQV) United States $35.950B 19.81
IDEXX Laboratories (IDXX) United States $34.289B 40.38
DexCom (DXCM) United States $33.759B 50.84
Waters (WAT) United States $23.998B 35.49
STERIS (STE) Ireland $21.743B 25.03
SONOVA HOLDING (SONVY) Switzerland $20.798B 0.00
Hologic (HOLX) United States $16.119B 17.50
Fresenius Medical Care AG KGaA (FMS) Germany $14.577B 14.96
Globus Medical (GMED) United States $12.635B 32.00
Sysmex ADR (SSMXY) Japan $12.243B 38.39
Penumbra (PEN) United States $10.352B 101.40
Masimo (MASI) United States $9.509B 46.01
Glaukos (GKOS) United States $8.767B 0.00
Teleflex (TFX) United States $8.387B 13.38
Integer Holdings (ITGR) United States $4.804B 27.23
Inari Medical (NARI) United States $4.666B 0.00
PROCEPT BioRobotics (PRCT) United States $3.807B 0.00
Veracyte (VCYT) United States $3.444B 103.35
LivaNova (LIVN) United Kingdom $2.755B 15.90
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Tandem Diabetes Care (TNDM) United States $2.388B 0.00
Elekta AB (EKTAY) Sweden $2.309B 20.76
TransMedics (TMDX) United States $2.199B 69.71
Integra LifeSciences Holdings (IART) United States $2.016B 10.53
Alphatec Holdings (ATEC) United States $1.710B 0.00
Artivion (AORT) United States $1.309B 86.72
RxSight (RXST) United States $1.273B 0.00
Pulse Biosciences (PLSE) United States $1.214B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.806B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.795B 13.51
IRadimed (IRMD) United States $0.759B 40.99
Mesa Laboratories (MLAB) United States $0.743B 17.51
SiBone (SIBN) United States $0.722B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.715B 0.00
Treace Medical Concepts (TMCI) United States $0.649B 0.00
OrthoPediatrics (KIDS) United States $0.602B 0.00
AngioDynamics (ANGO) United States $0.504B 0.00
Delcath Systems (DCTH) United States $0.500B 0.00
ClearPoint Neuro (CLPT) United States $0.491B 0.00
Semler Scientific (SMLR) United States $0.483B 25.41
NeuroPace (NPCE) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.429B 23.23
Pacific Biosciences Of California (PACB) United States $0.427B 0.00
CVRx (CVRX) United States $0.409B 0.00
Inogen (INGN) United States $0.298B 0.00
Alpha Tau Medical (DRTS) Israel $0.255B 0.00
Accuray (ARAY) United States $0.223B 0.00
Anteris Technologies Global (AVR) Australia $0.214B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
Nevro (NVRO) United States $0.190B 0.00
Sight Sciences (SGHT) United States $0.155B 0.00
LENSAR (LNSR) United States $0.129B 0.00
Sensus Healthcare (SRTS) United States $0.110B 11.75
Atossa Genetics (ATOS) United States $0.107B 0.00
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Neuronetics (STIM) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Rapid Micro Biosystems (RPID) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
EnVVeno Medical (NVNO) United States $0.055B 0.00
Lucid Diagnostics (LUCD) United States $0.053B 0.00
Positron (POSC) United States $0.051B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.036B 0.00
WORK Medical Technology Group (WOK) China $0.036B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00